North America continues to dominate the diabetic ulcer treatment market due to the high burden of diabetes, increasing healthcare expenditure, and strong presence of leading medical device and wound care companies. The region benefits from advanced healthcare facilities, growing utilization of bioengineered skin substitutes, negative pressure wound therapy, and antimicrobial dressings, along...